Literature DB >> 9888639

Role of lipoprotein lipases in postprandial lipid metabolism.

H Jansen1, B Breedveld, K Schoonderwoerd.   

Abstract

The pivotal role of heparin-releasable lipases in the clearing of postprandial lipids is known for a long time. The hydrolysis of triglycerides under influence of lipoprotein lipase is among the first recognised and well defined processes in postprandial lipid metabolism. More recently, also hepatic lipase has been implicated in the clearing of postprandial lipoproteins. Lipoprotein lipase as well as hepatic lipase are also involved in the metabolism of several other lipoproteins. However, their capacity is limited. This may lead to interaction of different metabolic processes and competition for the available lipase by different lipoproteins. Indeed, it is generally accepted that the exaggerated postprandial response in subjects with hypertriglyceridemia is at least partially due to competition between endogenous (VLDL) and exogenous (chylomicrons) lipoproteins. Similar mechanisms may also take place in the liver where hepatic lipase plays a role in the metabolism of several lipoproteins. In this short review, the roles of lipoprotein lipase and hepatic lipase in postprandial lipoprotein metabolism are discussed in relation(s) to their suggested function in the metabolism of different lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888639     DOI: 10.1016/s0021-9150(98)00214-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

Review 1.  High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.

Authors:  R A Wilke
Journal:  Pharmacogenomics J       Date:  2010-12-14       Impact factor: 3.550

2.  Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults.

Authors:  Jennifer A Nettleton; Lyn M Steffen; Christie M Ballantyne; Eric Boerwinkle; Aaron R Folsom
Journal:  Atherosclerosis       Date:  2006-12-08       Impact factor: 5.162

3.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

4.  Crocetin improves the insulin resistance induced by high-fat diet in rats.

Authors:  L Sheng; Z Qian; Y Shi; L Yang; L Xi; B Zhao; X Xu; H Ji
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

5.  Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.

Authors:  Márcia Dias Teixeira Carvalho; Diego Peres Alonso; Célia Maria Vieira Vendrame; Dorcas Lamounier Costa; Carlos Henrique Nery Costa; Guilherme Loureiro Werneck; Paulo Eduardo Martins Ribolla; Hiro Goto
Journal:  Mediators Inflamm       Date:  2014-08-27       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.